RSSFDA Approves Orencia (abatacept) for Children with JIA
As of last week, parents will have one more option to help their children battle Juvenile Idiopathic Arthriti (JIA). The FDA has approved Orencia (abatacept) for the treatment of moderate to severe polyarticular JIA. This may be a very welcome treatment option for children who have not responded to TNF-inhibitors or other drugs already approved... Read more
